Access cutting-edge perimenopausal bone loss treatment through this clinical trial at a research site in University Park. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this University Park location
Preparing your pre-screening questions…
Access perimenopausal bone loss specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related perimenopausal bone loss treatment provided free
Check if you qualify for this perimenopausal bone loss clinical trial in University Park, PA
No-Cost Study Care
Local to University Park
Convenient for PA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Dietary interventions of prune consumption during the transmenopausal period are innovative methods to prevent bone loss. Modern medicine does not intervene to prevent or attenuate this highly vulnerable period of bone loss which, if successfully attenuated, can potentially prevent/delay osteoporosis in women. The transmenopausal period represents an opportunistic window for the study because bone loss is at its greatest at this time, with females losing as much as 6-7% of bone. If this project is successful at attenuating bone loss, it can immediately be disseminated to the public to promote prune consumption to slow down and attenuate perimenopausal bone loss. As such, this project could improve the long-term bone health of females and avoid or delay osteoporosis and improve quality of life. The long-term goal of this study is to test the novel hypothesis that prune consumption for 18 months during the 3-year transmenopausal period prevents the dramatic rate of bone loss in perimenopausal females during a window of heightened physiological vulnerability. At Penn State University, the study will compare the effects of 18 months of daily dietary consumption of 50 g of prunes (5-6) versus a no-prune control group on bone outcomes (bone mineral density, bone geometry), mechanistic factors (bone and inflammatory markers, inflammatory response of ex vivo cultured peripheral blood mononuclear cells, monocytes), and gut microbiome.
Sponsor: Penn State University
Yes, this clinical trial (NCT07120997) has an active research site in University Park, PA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for perimenopausal bone loss treatment options in University Park, PA, this clinical trial (NCT07120997) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our University Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced perimenopausal bone loss specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all perimenopausal bone loss clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in University Park — not just this study.
Browse Pulmonary Embolism Trials in University Park →